Abstract
Not long ago, in vitro fertilization was the stuff of science fiction.1 Even after the birth of the first baby from in vitro fertilization in 1978, such births were initially few and far between, and there was skepticism about the future of in vitro fertilization as a mainstream medical procedure. Insurance companies considered it experimental and therefore not eligible for coverage in benefit plans. Twenty years later, data collected by the Centers for Disease Control and Prevention from in vitro fertilization clinics in the United States2 indicated that more than 58,000 in vitro fertilization cycles were performed annually, resulting in . . .